Flagellin as a vaccine adjuvant

B Cui, X Liu, Y Fang, P Zhou, Y Zhang… - Expert review of …, 2018 - Taylor & Francis
Introduction: Bacterial flagellin, as a pathogen-associated molecular pattern (PAMP), can
activate both innate and adaptive immunity. Its unique structural characteristics endow an …

[HTML][HTML] Recombinant viruses as vaccines against viral diseases

APD Souza, L Haut, A Reyes-Sandoval… - Brazilian Journal of …, 2005 - SciELO Brasil
Vaccine approaches to infectious diseases are widely applied and appreciated. Amongst
them, vectors based on recombinant viruses have shown great promise and play an …

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

JW Huleatt, AR Jacobs, J Tang, P Desai, EB Kopp… - Vaccine, 2007 - Elsevier
Recognition of specific pathogen associated molecular patterns (PAMPs) is mediated
primarily by members of the Toll-like receptor (TLR) family. Stimulation through these …

[HTML][HTML] Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice

MA Croyle, A Patel, KN Tran, M Gray, Y Zhang… - PloS one, 2008 - journals.plos.org
Pre-existing immunity to human adenovirus serotype 5 (Ad5) is common in the general
population. Bypassing pre-existing immunity could maximize Ad5 vaccine efficacy …

Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier

ZQ Xiang, GP Gao, A Reyes-Sandoval, Y Li… - Journal of …, 2003 - Am Soc Microbiol
ABSTRACT E1 deletion adenoviral vectors of the human serotype 5 (AdHu5) and the
chimpanzee serotype 68 (AdC68) expressing the rabies virus glycoprotein (rab. gp) were …

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for …

Y Chen, DC Yu, D Charlton, DR Henderson - Human gene therapy, 2000 - liebertpub.com
Pre-existent humoral antibody to adenovirus potentially confounds human clinical trials
involving intravascular administration of adenovirus. Using the LNCaP prostate cancer …

Recombinant viral vectors: cancer vaccines

R Harrop, J John, MW Carroll - Advanced drug delivery reviews, 2006 - Elsevier
To date cancer vaccines have yet to show efficacy in a phase III trial. However, the clinical
benefit seen with monoclonal antibody mediated therapies (eg, Herceptin) has provided …

Use of adenoviral vectors as veterinary vaccines

TB Ferreira, PM Alves, JG Aunins, MJT Carrondo - Gene therapy, 2005 - nature.com
Vaccines are the most effective and inexpensive prophylactic tool in veterinary medicine.
Ideally, vaccines should induce a lifelong protective immunity against the target pathogen …

Vaccination by Genetically Modified Dendritic Cells Expressing a Truncated neu Oncogene Prevents Development of Breast Cancer in Transgenic Mice

Y Sakai, BJ Morrison, JD Burke, JM Park, M Terabe… - Cancer research, 2004 - AACR
Dendritic cells (DCs) are powerful antigen-presenting cells that process antigens and
present peptide epitopes in the context of the major histocompatibility complex molecules to …

A new genetic vaccine platform based on an adeno-associated virus isolated from a rhesus macaque

J Lin, R Calcedo, LH Vandenberghe, P Bell… - Journal of …, 2009 - Am Soc Microbiol
We created a hybrid adeno-associated virus (AAV) from two related rhesus macaque
isolates, called AAVrh32. 33, and evaluated it as a vaccine carrier for human …